Differences between paediatric and adult suspected neuropsychiatric adverse drug reactions of Melatonin reported to the European Medicines Agency

References

• Owens J. Classification and epidemiology of childhood sleep disorders. Sleep Med Clin. 2007;2(3):353–361.
   Google Scholar
• Choi D. Potency of melatonin in living beings. Dev. Reprod. 2013;17(3):149–177.
   PubMedGoogle Scholar
• Chen CQ, Fichna J, Bashashati M, et al. Distribution, function and physiological role of melatonin in the lower gut. W J Gastro. 2011;17(34):3888–3898.
   PubMed Web of Science ®Google Scholar
• Tosini G, Baba K, Hwang CK, et al. Melatonin: an underappreciated player in retinal physiology and pathophysiology. J Exp Eye Res. 2012;103:82–89.
   PubMed Web of Science ®Google Scholar
• Maronde E, Pfeffer M, Olcese J, et al. Transcription factors in neuroendocrine regulation: rhythmic changes in pCREB and ICER levels frame melatonin synthesis. J Neurosci. 1999;19(9):3326–3336.
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol. 1991;79(1–3):53–158.
   PubMed Web of Science ®Google Scholar
• Fulia F, Gitto E, Cuzzocrea S. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res. 2001;31:343–349.
   PubMed Web of Science ®Google Scholar
• Meng X, Li Y, Li S, et al. Dietary sources and bioactivities of melatonin. Nutrients. 2017;9(4):367.
   PubMed Web of Science ®Google Scholar
• EMA.europe.eu. Еuropean medicines agency. Summary of product characteristics Cyrcadin [Internet], 2007 [cited 30 May 2019]. Available from: https://www.ema.europa.eu/en/documents/product-information/circadin-epar-product-information_en.pdf.
   Google Scholar
• BussinesWire.com. Businesswire melatonin supplements market - drivers and forecasts by Technavio [Internet], 2017 [cited 30 May 2019]. Available from: https://www.businesswire.com/news/home/20170825005517/en/Melatonin-Supplements-Market-Drivers-Forecasts-Technavio.
   Google Scholar
• ANSM.sante.fr [Internet] Agence nationale de securite du medicament et des produits de sante RTU- Protocole Circadin juillet 15 [Internet]. ANSM. 2015. [cited 30 May 2019]. Available from: https://ansm.sante.fr/var/ansm_site/storage/original/application/58c9957ff3346fd8dc4072da68e8a54f.pdf.
   Google Scholar
• EMA.europe.eu. European Medicines Agency. Assessment report Slenyto[Internet]. 2018. Publication number EMA/556280/2018 [cited 30 May 2019]. Available from: https://www.ema.europa.eu/documents/assessment-report/slenyto-epar-public-assessment-report_en.pdf.
   Google Scholar
• Wurtman RJ, Axelrod J, Chu EW. Melatonin, a pineal substance: effect on the rat ovary. Science. 1963;141:277–278.
   PubMed Web of Science ®Google Scholar
• Kennaway DJ. Melatonin use in paediatrics. J Paediatr Child Health. 2015;51:584–589..
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 1991;12:151–180.
   PubMed Web of Science ®Google Scholar
• Waldhauser F, Frisch H, Weissenbacher G, et al. Day- and nighttime serum melatonin in children and adults. Pediatr Res. 1981;15(12):1566–1566..
   Web of Science ®Google Scholar
• EMA.europe.eu. European Medicines Agency. EudraVigilance [Internet]. 2017 [cited 30 May 2019]. Available from: https://www.ema.europa.eu/en/human-regulatory/research-development/pharmacovigilance/eudravigilance.
   Google Scholar
• MedDRA.org. Medical dictionary for regulatory activities MedDRA term selection: points to consider. Based on MedDRA Version 22.0 [Internet]. Release 4.17. 2019 [cited 30 May 2019]. Available from: https://www.meddra.org/how-to-use/support-documentation.
   Google Scholar
• EMA.europe.eu. European Medicines Agency. Process description for managing duplicates in the context of the Medical literature monitoring (MLM) service [Internet]. 2015. [cited 30 May 2019] Publication number EMA/262834/2015. Available from: https://www.ema.europa.eu/documents/other/process-description-managing-duplicates-context-medical-literature-monitoring-mlm-service_en.pdf.
   Google Scholar
• Pinheiro LC, Candore G, Zaccaria C, et al. An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilance. Pharmacoepidemiol Drug Saf. 2018;27(1):38–45.
   PubMed Web of Science ®Google Scholar
• Hoebert M, van der Heijden KB, van Geijlswijk IM, et al. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res. 2009;47(1):1–7.
   PubMed Web of Science ®Google Scholar
• Mindell JA, Emslie G, Blumer J, et al. Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatrics. 2006;117(6):e1223–1232.
   Web of Science ®Google Scholar
• Cummings C. Melatonin for the management of sleep disorders in children and adolescents. Paediatr Child Health. 2012;17(6):331–333.
   PubMed Web of Science ®Google Scholar
• Barrett JR1, Tracy DK, Giaroli G. To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2013;23(10):640–647.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhong R, Xiong W, et al. Melatonin increases reactive aggression in humans. J Psychopharmacol. 2017;234(19):2971–2978.
   Web of Science ®Google Scholar
• Jasnow AM, Huhman KL, Bartness TJ, et al. Short-day increases in aggression are inversely related to circulating testosterone concentrations in male siberian hamsters (phodopus sungorus). Horm. Behav. 2000;38(2):102–110.
   PubMed Web of Science ®Google Scholar
• Jasnow AM, Huhman KL, Bartness TJ, et al. Short days and exogenous melatonin increase aggression of male Syrian hamsters (Mesocricetus auratus). Horm. Behav. 2002;42(1):13–20.
   PubMed Web of Science ®Google Scholar
• Munley K, Deyoe J, Ren C, et al. Melatonin mediates seasonal transitions in aggressive behavior and circulating androgen profiles in male Siberian hamsters. Hormones and Behavior. 2020;117:104608.
   PubMed Web of Science ®Google Scholar
• Bazil CW, Short D, Crispin D, et al. Patients with intractable epilepsy have low melatonin, which increases following seizures. Neurology. 2000;55(11):1746–1748.
   PubMed Web of Science ®Google Scholar
• Sandyk R, Tsagas N, Anninos PA. Melatonin as a proconvulsive hormone in humans. Int J Neurosci. 1992;63(1–2):125–135.
   PubMed Web of Science ®Google Scholar
• Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet. 1998;351(9111):251254.
   Web of Science ®Google Scholar
• Niles LP, Pickering DS, Arciszewski MA. Effects of chronic melatonin administration on GABA and diazepam binding in rat brain. J Neural Transm. 1987;70(1–2):117–124.
   PubMed Web of Science ®Google Scholar
• Jain S, Besag FM. Does melatonin affect epileptic seizures?Drug Saf. 2013;36(4):207–215.
   PubMed Web of Science ®Google Scholar
• Arain M, Haque M, Johal L, et al. Maturation of the adolescent brain. Neuropsychiatr Dis Treat. 2013;9:449–461.
   PubMed Web of Science ®Google Scholar
• Privitera M, Walters M, Lee I, et al. Characteristics of people with self-reported stress-precipitated seizures. Epilepsy Behav. 2014;41:74–77.
   PubMed Web of Science ®Google Scholar
• Joëls M. Stress, the hippocampus, and epilepsy. Epilepsia. 2009; 50:586–597..
   PubMed Web of Science ®Google Scholar
• Pierpaoli W, Maestroni GJ. Melatonin: a principal neuroimmunoregulatory and anti-stress hormone: its anti-aging effects. Immunol Lett. 1987;16(3–4):355–361.
   PubMed Web of Science ®Google Scholar